NCT05566912

Brief Summary

Abstract Objective: This study was conducted to determine the knowledge levels of DM patients about the disease and insulin use, and their practices to avoid insulin injection pain. Methods: Data were collected from 399 patients who administered insulin injections in the study. Patient identification form, disease and treatment compliance form, Morisky-8 Treatment Adherence Scale (MMAS-8), and Visual Analog Scale were used for data collection. The data were collected by the same researcher by face-to-face interview technique.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
399

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 15, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 27, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 5, 2022

Completed
Last Updated

October 5, 2022

Status Verified

October 1, 2022

Enrollment Period

3 months

First QC Date

September 27, 2022

Last Update Submit

October 3, 2022

Conditions

Keywords

Insuline injection painlipohypertrophynursing care

Outcome Measures

Primary Outcomes (1)

  • Completing the surveys

    Completion of all questionnaires by patients

    7 months

Interventions

This research is a descriptive study

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals with diabetes between the ages of 18-65

You may qualify if:

  • Patients between the ages of 18-65, diagnosed with diabetes mellitus at least 1 year ago, injecting themselves with insulin.

You may not qualify if:

  • Having no communication problems, and having no mental illness were included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Selcuk University

Konya, Akşehir, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
7 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

September 27, 2022

First Posted

October 5, 2022

Study Start

October 15, 2021

Primary Completion

January 15, 2022

Study Completion

April 15, 2022

Last Updated

October 5, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations